Neuroendocrine Tumor Carcinoid
3 clinical trials · Condition
◉ Watch Neuroendocrine Tumor Carcinoid
| Record | Firm | Date |
|---|---|---|
| Pharmaceutical Management in Targeted Radioligand Therapy (NCT07389512) | Hospices Civils de Lyon | 2026-01-09 |
| Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors (NCT06472388) | AC Camargo Cancer Center | 2024-04-24 |
| 68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET (NCT05448157) | European Institute of Oncology | 2022-05-12 |
Track Neuroendocrine Tumor Carcinoid automatically
Every clearance here is in the API, with alerts when new ones post.